Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy
Update: 2025-08-07
Description
Interview with Ehsan Rahimy, MD, author of Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy. Hosted by Neil Bressler, MD.
Related Content:
Comments
In Channel






